No profile data available.
Haemonetics Corporation (HAE) is a healthcare company in the additional specific healthcare equipment industry, based in Boston, United States, with about 3,009 full-time employees.
It reported revenue of $1.33 billion for fiscal year 2026, down 2.0% from fiscal year 2025, and net income of $97.31 million. In Q1 2027 (the quarter ended June 30, 2026) revenue was $339.38 million, up 5.6% from a year before. Its largest business segment, MedSurg, brought in 44% of segment revenue in fiscal year 2026; United States was the largest region with 74%. Its market capitalization was $5.40 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments.
Haemonetics reported $1.33 billion in revenue for fiscal year 2026, down 2.0% from $1.36 billion in fiscal year 2025. In Q1 2027 revenue was $339.38 million.
MedSurg, with $588.30 million or 44% of segment revenue in fiscal year 2026. Next: Plasma (39%) and Blood Center (17%).
United States: 74% of revenue by region in fiscal year 2026, followed by Europe (14%).
$5.40 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (additional specific healthcare equipment) include GE HealthCare Technologies Inc. (GEHC), Align Technology, Inc. (ALGN), Telix Pharmaceuticals Limited (TLX), Envista Holdings Corporation (NVST).